ERBB2 and breast carcinoma: While each patient’s journey is unique, this review illustrates a representative case of bone metastatic breast cancer, featuring a patient with the most statistically common clinical features: Hormone Receptor (HR) positive, Human Epidermal growth factor Receptor 2 (HER2)-negative breast cancer without germline mutation.